COVID's New Face: What You Need to Know for October

COVID-19 remains a significant health concern, even as some may perceive it as a minor illness. Vaccination and boosters continue to be the most effective defenses against severe infection and hospitalization. Current data from September 18, 2026, indicates an increase in COVID-19 activity nationally.

The leading variant identified is SW.2, comprising approximately 21% of cases, followed by XFG.1.1 and RW.1.1. While no single strain dominates as in previous years, the overall trend shows rising cases. Symptoms for the SW.2 variant and other current strains are consistent with those seen previously, including body aches, congestion, dry cough, fatigue, fever, runny nose, and sore throat.

Loss of taste and smell, once a hallmark symptom, is now uncommon, making it crucial not to rely on this symptom for testing. The incubation period for the SW.2 variant is typically three to four days, shorter than in 2020. This shortened period means testing too early after exposure could yield false negatives.

At-home COVID tests remain effective for newer strains, as they target stable internal virus components. However, accurate testing requires following instructions carefully, proper timing to avoid false negatives, and ensuring the test has not expired. Medical consultation is advised for persistent or severe symptoms, especially for high-risk individuals.

In mid-January 2026, COVID-19 was responsible for one in every 125 deaths in the US, highlighting its continued severity. Individuals experiencing severe symptoms like difficulty breathing, chest pain, confusion, or persistent fever should seek immediate medical attention. Prompt testing and consultation with a clinician are recommended for those with risk factors for severe COVID-19.